GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] special authorization is doing more work than we give it credit for — 66 comments in the full submission. View in context.
1.4k
c/glp1canada·submitted 1 year ago by u/erez_baptista

[Discussion] special authorization is doing more work than we give it credit for

Discussionbranch of 6 comments

Thinking out loud about this: special authorization is doing more work than we give it credit for. Cash pricing, which people skip because they assume coverage is the only route. Prices at the counter vary between pharmacies, sometimes substantially, in the same city. Members here have found spreads worth a real…

Read the full submission and all 66 comments →

This branch

6 comments, started 1 year ago
u/isabela_guerrero5 points·1 year ago

Quantity limits restrict how much may be dispensed in a period even where coverage exists. They are a distinct barrier and require a distinct request.

replysharereportpermalink
u/gradient_goblin3 points·1 year ago·edited

What did the denial actually say?

replysharereportpermalink
u/sequence_checkerresearch peptides2 points·1 year ago

Same view — private and provincial plans are genuinely different processes with different appeal routes.

replysharereportpermalink
u/ignacio_silva4 points·1 year ago

the exception drug status route exists in several provinces

replysharereportpermalink
u/greta_lokken4 points·1 year ago

the pharmacist is often the fastest route to a definite answer

replysharereportpermalink
u/emil_barros2 points·1 year ago

Yes. Cash prices vary and comparing them before assuming coverage is the only route is worth doing.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.